Literature DB >> 2175591

Humoral and cell-mediated immune responses to the glycoproteins of infectious laryngotracheitis herpesvirus.

J J York1, K J Fahey.   

Abstract

The viral glycoproteins of infectious laryngotracheitis virus, an alphaherpesvirus, were the dominant antigens recognised by immune chickens. Glycoproteins with molecular weights of 205, 160, 115, 90, 67, 60, and 52k reacted strongly in Western blotting studies with a majority of chicken antisera. Viral glycoproteins immunoprecipitated using monoclonal antibodies were also able to elicit a delayed-type hypersensitivity reaction in chickens previously vaccinated with a live vaccine. The 60 k glycoprotein alone and the antigenically related family of higher molecular weight glycoproteins (205, 160, 115, 90, and 85 k) both elicited significant increased in the thickness of the wattles of immune cockerels. Because the glycoproteins induce both antibody and cell-mediated immune responses they may prove to be important protective immunogens in a subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175591     DOI: 10.1007/BF01310537

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells.

Authors:  C C Marchioli; R J Yancey; E A Petrovskis; J G Timmins; L E Post
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.

Authors:  J Kahlon; F D Lakeman; M Ackermann; R J Whitley
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

3.  The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.

Authors:  R Eberle; S W Mou; J A Zaia
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

4.  Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Authors:  D Long; T J Madara; M Ponce de Leon; G H Cohen; P C Montgomery; R J Eisenberg
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.

Authors:  K J Cremer; M Mackett; C Wohlenberg; A L Notkins; B Moss
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

6.  Immunological reactivity of human sera with individual herpes simplex proteins: a comparative study of sera from patients with preinvasive or invasive cervical cancer and from controls.

Authors:  C S Teglbjaerg; R Feldborg; B Norrild
Journal:  J Med Virol       Date:  1986-02       Impact factor: 2.327

7.  The role of bursa-dependent responses in immunity to infectious laryngotracheitis.

Authors:  G M Robertson
Journal:  Res Vet Sci       Date:  1977-05       Impact factor: 2.534

8.  Laryngotracheitis herpesvirus infection in the chicken: the role of humoral antibody in immunity to a graded challenge infection.

Authors:  K J Fahey; T J Bagust; J J York
Journal:  Avian Pathol       Date:  1983-10       Impact factor: 3.378

9.  Laryngotracheitis herpesvirus infection in the chicken. II. The adoptive transfer of resistance with immune spleen cells.

Authors:  K J Fahey; J J York; T J Bagust
Journal:  Avian Pathol       Date:  1984-04       Impact factor: 3.378

10.  Identification of major antigenic proteins of bovine herpesvirus 1 and their correlation with virus neutralizing activity.

Authors:  N A Scott; J M Whalley; J S Mattick; P A Underwood; L Aboud; K L Williams; P Kirkland
Journal:  Vet Microbiol       Date:  1988-02       Impact factor: 3.293

View more
  4 in total

1.  Antigens of infectious laryngotracheitis herpesvirus defined by monoclonal antibodies.

Authors:  J J York; S Sonza; M R Brandon; K J Fahey
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Host Responses Following Infection with Canadian-Origin Wildtype and Vaccine Revertant Infectious Laryngotracheitis Virus.

Authors:  Esraa A Elshafiee; Ishara M Isham; Shahnas M Najimudeen; Ana Perez-Contreras; Catalina Barboza-Solis; Madhu Ravi; Mohamed Faizal Abdul-Careem
Journal:  Vaccines (Basel)       Date:  2022-05-16

3.  Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control - a comprehensive review.

Authors:  Vasudevan Gowthaman; Sachin Kumar; Monika Koul; Urmil Dave; T R Gopala Krishna Murthy; Palanivelu Munuswamy; Ruchi Tiwari; Kumaragurubaran Karthik; Kuldeep Dhama; Izabela Michalak; Sunil K Joshi
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

4.  Evaluation of Recombinant Herpesvirus of Turkey Laryngotracheitis (rHVT-LT) Vaccine against Genotype VI Canadian Wild-Type Infectious Laryngotracheitis Virus (ILTV) Infection.

Authors:  Catalina Barboza-Solis; Shahnas M Najimudeen; Ana Perez-Contreras; Ahmed Ali; Tomy Joseph; Robin King; Madhu Ravi; Delores Peters; Kevin Fonseca; Carl A Gagnon; Frank van der Meer; Mohamed Faizal Abdul-Careem
Journal:  Vaccines (Basel)       Date:  2021-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.